Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 22.6B | 23.5B | 20.7B | 21.7B |
Cost of revenue | 19.6B | 21.7B | 18.7B | 19.0B |
Gross profit | 2.9B | 1.8B | 2.0B | 2.7B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 870M | 783M | 818M | 822M |
Other operating expenses | -274M | — | -32M | 109M |
Operating income | 2.3B | 1.3B | 1.2B | 2.1B |
Non operating interest income | ||||
Income | 2.2B | 3.2B | 1.7B | 1.4B |
Expense | 2.5B | 3.5B | 2.1B | 1.6B |
Other income expense | 333M | -966M | 855M | 224M |
Pretax income | 2.4B | 44M | 1.6B | 2.1B |
Tax provision | 1.2B | -244M | 1.1B | 1.4B |
Net income | 1.2B | 288M | 544M | 695M |
Basic EPS | 0.4 | — | 0.2 | — |
Diluted EPS | 0.4 | — | 0.2 | — |
Basic average shares | 3.1B | — | 3.2B | — |
Diluted average shares | 3.1B | — | 3.2B | — |
EBITDA | 7.2B | 6.9B | 5.2B | 7.1B |
Net income from continuing op. | 1.2B | 288M | 544M | 695M |
Minority interests | -23M | -58M | -22M | -34M |
Preferred stock dividends | — | — | — | — |